Uncategorized
Icon Bioscience Receives FDA Approval for DEXYCU™, a Potentially Transformational Drug Therapy for Treating Inflammation Associated with Cataract Surgery
NEWARK, Calif.--(BUSINESS WIRE)--DEXYCU breaks new ground in the treatment of inflammation in post cataract surgery